Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Patiromer Sorbitex Calcium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 407Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as:
    Molecular Formula
    C50H62CaF2O10
    Molecular Weight
    901.1  g/mol
    InChI Key
    KDDZXVQCHUXALQ-NIQIMLPHSA-L
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    calcium;1,2-bis(ethenyl)benzene;1,3-bis(ethenyl)benzene;1,4-bis(ethenyl)benzene;2-fluoroprop-2-enoate;(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;octa-1,7-diene
    2.1.2 InChI
    InChI=1S/3C10H10.C8H14.C6H14O6.2C3H3FO2.Ca/c1-3-9-5-7-10(4-2)8-6-9;1-3-9-6-5-7-10(4-2)8-9;1-3-9-7-5-6-8-10(9)4-2;1-3-5-7-8-6-4-2;7-1-3(9)5(11)6(12)4(10)2-8;2*1-2(4)3(5)6;/h3*3-8H,1-2H2;3-4H,1-2,5-8H2;3-12H,1-2H2;2*1H2,(H,5,6);/q;;;;;;;+2/p-2/t;;;;3-,4+,5-,6-;;;/m....1.../s1
    2.1.3 InChI Key
    KDDZXVQCHUXALQ-NIQIMLPHSA-L
    2.1.4 Canonical SMILES
    C=CCCCCC=C.C=CC1=CC=C(C=C1)C=C.C=CC1=CC(=CC=C1)C=C.C=CC1=CC=CC=C1C=C.C=C(C(=O)[O-])F.C=C(C(=O)[O-])F.C(C(C(C(C(CO)O)O)O)O)O.[Ca+2]
    2.1.5 Isomeric SMILES
    C=CCCCCC=C.C=CC1=CC=C(C=C1)C=C.C=CC1=CC(=CC=C1)C=C.C=CC1=CC=CC=C1C=C.C=C(C(=O)[O-])F.C=C(C(=O)[O-])F.C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O.[Ca+2]
    2.2 Create Date
    2015-01-24
    3 Chemical and Physical Properties
    Molecular Weight 901.1 g/mol
    Molecular Formula C50H62CaF2O10
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count16
    Exact Mass900.3936953 g/mol
    Monoisotopic Mass900.3936953 g/mol
    Topological Polar Surface Area202 A^2
    Heavy Atom Count63
    Formal Charge0
    Complexity556
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count8
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 1  
    Drug NameVELTASSA
    Active IngredientPATIROMER SORBITEX CALCIUM
    CompanyRELYPSA INC (Application Number: N205739. Patents: 7556799, 8147873, 8216560, 8282913, 8287847, 8337824, 8475780, 8778324, 8889115, 9492476, 9925212)